Success Story: I-140 NIW Approved for an Internal Medicine Researcher in Diabetes Management
Client’s Testimonial:
“Thank you for your support and assistance.”
On August 15th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician in the Field of Internal Medicine (Approval Notice).
General Field: Internal Medicine
Position at the Time of Case Filing: Resident Physician
Country of Origin: Palestine
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: August 15th, 2026
Processing Time: 17 months, 22 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group successfully secured an EB-2 National Interest Waiver (NIW) for a medical researcher operating in the field of internal medicine. Currently employed as a resident physician at a U.S. medical center, the client focuses his research on improving the understanding and management of diabetes through targeted weight loss and lifestyle interventions. By investigating long-term patient outcomes, the client provides healthcare systems with evidence-based strategies to mitigate diabetic complications, improve patient care, and alleviate systemic healthcare costs.
To satisfy the legal framework under Matter of Dhanasar, our team built an evidentiary portfolio demonstrating that an adjudicating officer should view the client's achievements as evidence of field-wide influence rather than standard academic output:
- Academic & Professional Background: Possession of a medical degree (M.D.) alongside specialized clinical research fellowship training focusing on diabetes and metabolic complications.
- Scholarly Publication Output: Authorship of 7 peer-reviewed journal articles (1 co-first-authored) and 10 conference abstracts (3 first-authored), featured in premier medical publications.
- Citation Impact & Percentiles: Accumulation of 47 citations across his published body of work. We contextualized this metric using bibliometric percentiles to prove that five of his articles rank in the top 10% and one ranks in the top 20% of most-cited clinical medicine papers for their publication years.
Beyond publication metrics, we clearly linked the client’s research to pressing U.S. health priorities. We highlighted how independent clinical researchers rely on his studies to advance treatments for non-alcoholic fatty liver disease, optimize hybrid care models, and refine obesity management.
USCIS acknowledged the clear substantial merit and national importance of the client's work, granting the I-140 NIW petition approval without any RFE issues.